The simple DIY pump made from a balloon and stockings.
A simple pressure pump, made from balloons and nylon stockings, means more people in more places will be able to test water contaminants and blood samples.
The ingenious device unveiled in the prestigious Lab on a Chip journal cost just $2 to make, yet works almost as well as its expensive and cumbersome lab counterparts.
Pumps are used to make biological samples flow through microfluidic devices while their contents are identified beneath a microscope.
This DIY pump came from a collaboration between researchers at RMIT University and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, who demonstrated its viability in tests to detect aquatic parasites and cancer cells and to study vascular diseases.
Inspired by football
Study lead author and RMIT engineer, Dr Peter Thurgood,said the team took inspiration for the simple invention from footballs, which hold large pressures when reinforced.
“We started with basic latex balloons, then realised that regular stockings made from nylon and elastane could be a perfect match to reinforce them, allowing them to hold significantly higher pressure and function as pumps,” Thurgood said.
“By simply wrapping three layers of stockings around the latex balloon we were able to increase its internal pressure by a factor of 10 – enough to run many water or blood analyses that would usually require large, expensive pumps.”
Experiments showed the reinforced balloon pump could be used to operate microfluidic devices for several hours without a significant pressure loss.
The pump also fits easily within an incubator and can be left overnight.
A low-cost field tool where it’s needed most
Study co-author and parasitologist at the Walter and Eliza Hall Institute,Associate Professor Aaron Jex, is a leading researcher in global water quality and public health interventions.
He said this simple innovation opened exciting opportunities in field water testing and the ability to test and diagnose patients for infectious pathogens and aquatic micro-organisms at the point-of-care.
“Parasitic micro-organisms have a major impact in impoverished communities in tropical and subtropical regions globally, but also in developed countries including Australia,” Jex said.
“In order to address this there is an urgent need for field-based, low-cost diagnostic tools that work in challenging, sometimes remote and often complex environments very different from a pristine laboratory.”
“As simple as it may look, this device suits those needs really well and could have a big impact.”
Co-author and RMIT biologist, Dr Sara Baratchi, said it also had promising applications for early diagnosis of diseases at home or in the doctor’s surgery.
The balloon pump was tested as a point-of-care diagnostic device for detection of very low concentrations of target cancer cells in liquid samples, and found to work.
“The hydrodynamic force of liquid produced by the reinforced balloon was enough to isolate cells for study, which was really amazing for a $2 pump!”
Baratchi is now working on applying the simplified pump technology to develop organ-on-chip systems that mimic the flow conditions in dysfunctional vessels, to better understand diseases like atherosclerosis that lead to heart attack and stroke.
An opportunity for outreach
RMIT engineer and project leader, Dr Khashayar Khoshmanesh,is a leading researcher in the field of microfluidic based lab-on-a-chip technologies.
He said while microfluidics had made significant progress over the past decade, their widespread application had been limited by the cost and bulk of pumps required to operate them.
“Simplicity is at the heart of our entire research program. By redesigning sophisticated microfluidic devices into simplified ones, we can maximise their outreach and applications for use in teaching or research in the field, not just in sophisticated labs,” he said.
“We envisage these types of pumps also being suitable for student classwork experiments to support capability development in this important area of research from an earlier stage.”
The Latest on: Point-of-care diagnostic device
via Google News
The Latest on: Point-of-care diagnostic device
- Therma Bright Submits Health Canada Application for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test for Point-of-Care (POC)on June 27, 2022 at 3:10 pm
Toronto, Ontario--(Newsfile Corp. - June 23, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva ...
- Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product, By End-use, By Region And Segment Forecasts, 2022 - 2030on June 24, 2022 at 6:25 am
Reportlinker.com announces the release of the report "Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product, By End-use, By Region And Segment Forecasts, 2022 - 2030" - ...
- Therma Bright submits Health Canada application for its AcuVid COVID-19 rapid antigen saliva test for point-of-care useon June 24, 2022 at 2:40 am
The Toronto-based company said the application includes all the updated data from the company's US Food and Drug Administration's ...
- The IVD raw materials market by revenue is expected to grow at a CAGR of 5.86% during 2022-2027on June 22, 2022 at 1:30 am
The Europe region is one of the matured markets for in-vitro diagnostic; the large laboratory instruments are highly automated compared to most point-of-care testing devices. Automation has increased ...
- IVD Raw Materials Market to Reach $34.25 Billion by 2027. Molecular Point-of-Care (POC) Replacing Existing Limitations at POC sites – Ariztonon June 15, 2022 at 3:07 pm
The increasing prevalence of infectious & chronic diseases, growing awareness of early diagnosis and disease prevention, and rise in availability of advanced home care kits for cancer diagnostics are ...
- Mindray Reimagines Point of Care Systems with Launch of New TEX20 Diagnostic Ultrasound Series at Euroanaesthesia 2022on June 15, 2022 at 6:18 am
SHENZHEN, China, June 15, 2022 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has launched its best-in-class Point of Care ...
- 5 things you should know about at-home diagnostic testingon June 10, 2022 at 1:10 pm
The Food and Drug Administration (FDA) regulates manufacturers and devices under the Federal ... the difference between at-home diagnostic tests and point-of-care tests. Users take point-of ...
- New SMA/PMMA alloy developed for point-of-care diagnostic deviceson June 6, 2022 at 5:00 pm
Point-of-care (POC) testing is a rapidly growing segment of the ... undergoing regulatory review and will be on the market soon, said Polyscope. POC diagnostic devices are small, often handheld, ...
- The Benefits of Frangible Seals in Diagnostic Point-of-Care Testingon June 2, 2022 at 5:00 pm
With more than 20 years of experience in the medical device and diagnostics industry, he is responsible for seeking new business development opportunities with companies across the point-of-care ...
- Startup Developing Point-of-Care HIV-testing Device Seeks $15Mon June 2, 2022 at 5:00 pm
Allere makes such a point of care device. Myatt says that it is “a solid product but ... Myatt is in discussions with European investors as well as well-known diagnostic companies. He also plans to ...
via Bing News